THE RESOLUTION OF EXPERT BOARD MEETING ON ROTAVIRUS INFECTION AND CURRENT POSSIBILITIES OF PREVENTIVE VACCINATION

1. State report «О sostoyanii sanitarno-epidemio-logicheskogo blagopoluchiya naseleniya v Rossijskoj Federatsii v 2017 godu». (In Russ). Доступно по: https://rospotrebnadzor.ru/documents/details.php?ELEMENTJD=10145. Ссылка активна на 20.06.2019.

2. Gervasi G, Capanna A, Mita V, et al. Nosocomial rotavirus infection: an up to date evaluation of European studies. Hum Vaccin Immunother. 2016;12(9):2413-2418. doi: 10.1080/21645515.2016.1183858.

3. Koch J, Wiese-Posselt M, Remschmidt C, et al. Background paper to the recommendation for routine rotavirus vaccination of infants in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(7):957-984. doi: 10.1007/s00103-013-1777-3.

4. Vorobyeva MA, Krasnov VV, Sidorenkova EV, et al. The case of serous meningitis rotavirus etiology in a four-year-old child. Children's Infections. 2017;16(2):60-63. (In Russ). doi: 10.22627/2072-8107-2017-16-2-60-63.

5. Dickey M, Jamison L, Michaud L, et al. Rotavirus meningoencephalitis in a previously healthy child and a review of the literature. Pediatr Infect Dis J. 2009;28(4):318-321. doi: 10.1097/INF.0b013e31818ddbe9.

6. Heyse JF, Kuter BJ, Dallas MJ, Heaton P; REST Study Team. Evaluating the safety of a rotavirus vaccine: the REST of the story. Clin Trials. 2008;5(2):131-139. doi: 10.1177/1740774508090507.

7. Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23-33.

8. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11-22.

9. Isanaka S, Guindo O, Langendorf C, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in niger. N Engl J Med. 2017; 376(12):1121-1130. doi: 10.1056/NEJMoa1609462.

10. Kulkarni PS, Desai S, Tewari T, et al. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017;35(45):6228-6237. doi: 10.1016/j.vaccine.2017.09.014.

11. Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9935):2136-2143. doi: 10.1016/S0140-6736(13)62630-6.

12. Presidential Order Ministry of Health № 125н «Ob utverzhdenii regional’nogo kalendarya profilakticheskikh privivok i kalendarya profilakticheskikh privivok po epidemicheskim poka-zaniyam» (Spisok izmenyayushchikh dokumentov v red. Prikaza Minzdrava Rossii ot 16.06.2016 № 370n) dated 2014 March 21 (In Russ). Доступно по: https://docplayer.ru/43843685-Minis-terstvo-zdravoohraneniya-rossiyskoy-federacii-prikaz-ot-21-marta-2014-g-n-125n.html. Ссылка активна на 20.06.2019.

13. Martynova GP, Yuzhakova AG, Solovieva IA, Tretyakov AP. Rotavirus infection in children of Krasnoyarsk region: first steps to reduce the incidence. Farmateka. 2016;(11):45-50. (In Russ).

14. Rychkova OA, Kazakevich NV, Dubinina OA, et al. Prevention of rotavirus infection: the way of expansion of the regional vaccination program in Tyumen region. Farmateka. 2016;(11):106-111. (In Russ).

15. Smirnova SS, Golubkova AA, Koltunov SV. Experience of vaccination against rotavirus gastroenteritis in the Sverdlovsk region. Epidemiologiya i vaktsinoprofilaktika. 2018;17(3):68-73. (In Russ). doi: 10.31631/2073-3046-2018-17-3-68-73.

16. Girina AA, Kurganskaya AYu. A clinico-epidemiological characteristic and possibilities of preventing rotavirus infection in children of the Khanty-Mansi Autonomous Area-Yugra. Infectious diseases. 2018;16(1):87-92. (In Russ). doi: 10.20953/1729-9225-2018-1-87-92.